We work to develop and deliver lifesaving vaccines to women, children, and communities around the globe.
Moving the Needle provides updates from CVIA on our vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing-country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine technologies.
Immunization Matters provides updates from CVIA on late-stage and licensed vaccines included in our portfolio as well as our work on health economics and optimization, operations research, and support to countries.
PATH’s Vaccine Cost Calculators provide an easy way to assess and compare costs of certain vaccination programs over a period of 10 years with each vaccine product available in the global market. These Excel-based tools are available in multiple languages for rotavirus vaccines, pneumococcal conjugate vaccines, and human papillomavirus vaccines (coming soon!).
PATH's Defeat Diarrheal Disease Initiative was started to raise awareness of the burden of diarrheal disease and help increase access to the solutions. We need your help to make a stink about the problem, and our website gives you the tools to do just that.
The BID Initiative is grounded in the belief that better data, plus better decisions, will lead to better health outcomes. We partner with countries to enhance overall health service delivery through improved data collection, quality, and use.
PATH's Malaria Vaccine Initiative (MVI) drives transformative innovation to save lives and improve health, especially among women and children. MVI works with partners in private industry, government, and academia to develop malaria vaccines.
The Coalition against Typhoid (CaT) and the Typhoid Vaccine Acceleration Consortium (TyVAC) have joined forces to Take on Typhoid. Together, we are working to focus attention on typhoid and the need for typhoid conjugate vaccines and water, sanitation, and hygiene interventions to reduce the burden and impact of typhoid fever.